Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04373265 |
| Title | Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Corcept Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Site #150, Stanford Cancer Center | Stanford | California | 94305 | United States | Details | |
| Site #007, Moffitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
| Site #074, University of Michigan Medical School | Ann Arbor | Michigan | 48109 | United States | Details | |
| Site #030 Mayo Clinic | Rochester | Minnesota | 55905 | United States | Details | |
| Site #051, Memorial Hospital | New York | New York | 10022 | United States | Details | |
| Site #183, The University of Texas M.D. Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |